Publications

Co-design and development of a community pharmacy-based CVD risk screening service in Saudi Arabia : a multi-stakeholders Nominal Group Technique (NGT) consensus method

Noorsaeed Solafa Mohamedwaly M, Almansour Hadi, Weir Natalie Mcfadyen, Kurdi Amanj

83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences (2025)

Co-design and development of a community pharmacy-based CVD risk screening service in Saudi Arabia : a Multi-stakeholders Nominal Group Technique (NGT) Consensus method

Noorsaeed Solafa Mohamedwaly M, Almansour Hadi, Weir Natalie Mcfadyen, Kurdi Amanj

NORDIC Social Pharmacy Conference 2025 (2025)

Exploring community pharmacy services in the Gulf cooperation council countries : a scoping review

Noorsaeed Solafa Mohamedwaly M, Alshammari Hisham Abdulaziz M, Weir Natalie Mcfadyen, Kurdi Amanj

International Journal of Pharmacy Practice (2025)

https://doi.org/10.1093/ijpp/riaf041

Knowledge gaps influencing inappropriate surgical antibiotic prophylaxis prescribing in Kuwait : qualitative study

Alshatti F, Boyter A, Taqi A, Kurdi A

11th Nordic Social Pharmacy Conference (2025)

A survey on Clostridioides difficile infection (CDI) testing in microbiology laboratories in Saudi Arabia: Findings and implications

Alnezary Faris, Almutairi Masaad S, Alsuwaylim Rasil, Albolwi Lubna, Alrehaili Manar, Alzahrani Fahad, Mahmoud Mansour, Kurdi Amanj, Godman Brian, Almohammed Omar, Thabit Abrar

Tropical Journal of Pharmaceutical Research Vol 24, pp. 731-738 (2025)

https://doi.org/10.4314/tjpr.v24i5.11

Investigating the contribution of socio-economic position to ethnic inequalities in severe COVID-19 outcomes : population-based mediation analyses of national linked Scottish data

Amele Sarah, Kibuchi Eliud, McCabe Ronan, Demou Evangelia, Leyland Alastair H, Hainey Kirsten, Rudan Igor, Kurdi Amanj, Simpson Colin R, Ritchie Lewis D, McCowan Colin, Shi Ting, Irizar Patricia, Becares Laia, Sheikh Aziz, Pearce Anna, Katikireddi Srinivasa Vittal

European Journal of Public Health (2025)

https://doi.org/10.1093/eurpub/ckaf078

More publications

Professional Activities

Invited Guest Speaker at the 15th International Congress of Pharmaceutical Sciences (CIFARP 2025)around Real-world evidence

Speaker

29/10/2025

External Examiner for the “Professional Certificate in Pharmacoepidemiology & Pharmacovigilance” course at London School of Hygiene and Tropical Medicine

Examiner

24/2/2025

Iraqi Journal of Pharmacy (Journal)

Peer reviewer

13/8/2024

Positioning Pharmacists in advancing Primary Health Care

Speaker

13/6/2024

Advances in Pharmacy and Pharmacoepidemiology Education in Kenya and Globally

Speaker

13/6/2024

Applied Pharmacoepidemology

Speaker

11/6/2024

More professional activities

Projects

Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies

Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)

01-Jan-2024 - 30-Jan-2025

Cancer Medicines Outcomes Programme - Public Health Scotland

Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)

The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.

01-Jan-2024 - 31-Jan-2027

Prescribing medicines use in pregnancy: A scoping review protocol

Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)

Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.

10-Jan-2024 - 14-Jan-2024

PHS Medicines Programme

Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)

01-Jan-2023 - 30-Jan-2028

Profiling and assessing medicines use in pregnancy in Scotland: a population-based, whole system prescribing approach using routine data from clinical care

Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Co-investigator)

01-Jan-2023 - 30-Jan-2027

22/145 Systems Engineering Innovation hubs for Multiple longterm Conditions - Development phase

Maier, Anja (Principal Investigator) Connolly, Patricia (Co-investigator) Gray, Louise (Co-investigator) Inns, Tom (Co-investigator) Kurdi, Amanj (Co-investigator) Maguire, Roma (Co-investigator) Mehnen, Jorn (Co-investigator) Michie, Craig (Co-investigator) Mueller, Tanja (Co-investigator) Picanco Rodrigues, Vinicius (Co-investigator) Tachtatzis, Christos (Co-investigator) Whitfield, Ian (Co-investigator)

01-Jan-2023 - 31-Jan-2025

More projects